Video laryngoscopy-assisted less-invasive surfactant administration quality improvement initiative.
Dalibor Kurepa, Vitaliya Boyar, Olena Predtechenska...
https://pubmed.ncbi.nlm.nih.gov/37028921/Actively Recruiting
Led by University of Texas Southwestern Medical Center · Updated on 2026-06-15
100
Participants Needed
1
Research Sites
21 weeks
Total Duration
Researchers are studying premature infants born between 22 and 28 weeks gestational age who need surfactant, a medicine that helps their lungs. The study compares two methods of visualization during a procedure called less invasive surfactant administration LISA to see which method has a higher success rate on the first attempt and what benefits each method offers. The study involves two groups one uses video laryngoscopy to see the vocal cords and place the catheter, while the other uses direct laryngoscopy without a camera for the same procedure. Both methods aim to deliver surfactant to the infants lungs with minimal invasiveness. Participants are monitored closely during and after the procedure for various factors such as oxygen levels, heart rate, the number of attempts, and any complications like pneumothorax or the need for intubation. The main outcome measured is how often the surfactant is successfully given on the first try. The study follows infants up to 90 days to assess survival and other health outcomes.
CONDITIONS
Video vs. Direct Laryngoscopy for Less Invasive Surfactant Administration
P
Principal Investigator, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Texas Southwestern Medical Center
Lead Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Video Laryngoscopy–guided LISA | Direct Laryngoscopy–guided LISA | Standard surfactant via intubation and mechanical ventilation |
|---|---|---|---|
| What it is | Less invasive surfactant is delivered via LISA using video laryngoscopy for visualization during catheter placement | Less invasive surfactant is delivered via LISA using standard direct laryngoscopy for catheter placement | Standard practice involves surfactant delivery via endotracheal tube with mechanical ventilation |
| Role in trial | Investigational arm meant to assess if visualization via video improves LISA success | Control arm using standard direct visualization for LISA catheter placement | Not part of trial but represents the broader current clinical approach for surfactant delivery |
| Primary use | Deliver surfactant via LISA with improved visualization | Deliver surfactant via LISA using direct visualization | Deliver surfactant via endotracheal intubation with mechanical ventilation support |
| How it is given or performed | Video laryngoscope is used to visualize the vocal cords and place a thin catheter for LISA | Standard direct laryngoscopy is used to place the LISA catheter under direct view | Surfactant is instilled through an endotracheal tube after intubation and supported by mechanical ventilation |
| Evidence status | Efficacy not yet established — trial is ongoing | Efficacy not yet established — being compared to video‑guided LISA in trial | Has established efficacy historically as standard surfactant delivery with mechanical ventilation |
| Important risks | Unknown — safety outcomes depend on trial findings | Unknown — safety risks are being tracked in the trial | Exposure to mechanical ventilation increases risk of lung injury and bronchopulmonary dysplasia |
| Important limitations | Effectiveness in improving first‑attempt success is not yet known | May have lower visualization compared to video; evidence in this setting pending | Associated with higher risk of lung injury and longer ventilation exposure compared to non‑invasive methods |
| Patient impact | Not yet determined — patient‑relevant outcomes await trial results | Not yet determined — being evaluated in trial | Associated with increased risk of bronchopulmonary dysplasia and prolonged ventilation in infants |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 36 hours after birth
Participants receive surfactant through either video laryngoscopy or direct laryngoscopy to help their lungs.
1 procedure visit
Duration - Up to 90 days
Participants are monitored for up to 90 days to assess procedure success, oxygen levels, heart rate, complications, and survival.
Regular assessments during hospital stay
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Dalibor Kurepa, Vitaliya Boyar, Olena Predtechenska...
https://pubmed.ncbi.nlm.nih.gov/37028921/Thomas Riva, Thomas Engelhardt, Reto Basciani...
https://pubmed.ncbi.nlm.nih.gov/36436541/Annery G Garcia-Marcinkiewicz, Pete G Kovatsis, Agnes I Hunyady...
https://pubmed.ncbi.nlm.nih.gov/33308472/Jose C Aldana-Aguirre, Merlin Pinto, Robin M Featherstone...
https://pubmed.ncbi.nlm.nih.gov/27852668/Lucy E Geraghty, Emma A Dunne, Caitríona M Ní Chathasaigh...
https://pubmed.ncbi.nlm.nih.gov/38709215/University of Texas Southwestern Medical Center
Lead Sponsor